Alan T. Hirsch mainly focuses on Internal medicine, Cardiology, Disease, Risk factor and Surgery. The various areas that Alan T. Hirsch examines in his Internal medicine study include Diabetes mellitus and Endocrinology. The concepts of his Cardiology study are interwoven with issues in Peripheral, Aspirin and Arterial disease.
He has included themes like Psychological intervention, Thrombosis and Physical therapy in his Disease study. His studies deal with areas such as Relative risk and Vascular disease as well as Risk factor. His studies examine the connections between Surgery and genetics, as well as such issues in Revascularization, with regards to Medical record and Peripheral artery disease.
Alan T. Hirsch mostly deals with Internal medicine, Cardiology, Surgery, Physical therapy and Disease. His study in Myocardial infarction, Stroke, Arterial disease, Risk factor and Intermittent claudication are all subfields of Internal medicine. His biological study deals with issues like Blood pressure, which deal with fields such as Hemodynamics.
His Surgery research is multidisciplinary, relying on both Coronary artery disease, Incidence and Diabetes mellitus. Revascularization, Treadmill and Randomized controlled trial is closely connected to Claudication in his research, which is encompassed under the umbrella topic of Physical therapy. His studies in Disease integrate themes in fields like Epidemiology and Intensive care medicine.
His primary areas of study are Internal medicine, Disease, Cardiology, Arterial disease and Physical therapy. His research on Internal medicine often connects related topics like Surgery. He interconnects Stroke, Rehabilitation and Myocardial infarction, Revascularization in the investigation of issues within Disease.
His Cardiology research incorporates themes from Creatinine, Intermittent claudication, Renal replacement therapy and Albuminuria. His Arterial disease study incorporates themes from Peripheral, Interventional radiology and Atherosclerosis Risk in Communities. His work carried out in the field of Physical therapy brings together such families of science as Epidemiology, Cohort, Cross-sectional study, Quality of life and Confounding.
Internal medicine, Surgery, Disease, Cardiology and Physical therapy are his primary areas of study. The Surgery study combines topics in areas such as Breast cancer, Axilla and Risk factor. His Disease study combines topics in areas such as Angioplasty, Stent, Myocardial infarction, Revascularization and Cilostazol.
His work deals with themes such as Appropriate Use Criteria and Randomized controlled trial, which intersect with Cardiology. Alan T. Hirsch combines subjects such as Lymphedema, Ambulatory care, Epidemiology, Managed care and Quality of life with his study of Physical therapy. As a part of the same scientific family, Alan T. Hirsch mostly works in the field of Epidemiology, focusing on Severity of illness and, on occasion, Peripheral.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
Alan T. Hirsch;Ziv J. Haskal;Norman R. Hertzer;Curtis W. Bakal.
Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care
Alan T Hirsch;Michael H. Criqui;Diane J Treat-Jacobson;Judith G. Regensteiner.
Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: A meta-analysis
F.G.R. Fowkes;G.D. Murray;I. Butcher;C.L. Heald.
International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis
Deepak L. Bhatt;P. Gabriel Steg;E. Magnus Ohman;Alan T. Hirsch.
One-Year Cardiovascular Event Rates in Outpatients With Atherothrombosis
Ph. Gabriel Steg;Deepak L. Bhatt;Peter W. F. Wilson;Ralph D’Agostino.
ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (Lower extremity, renal, mesenteric, and abdominal aortic): Executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vas
A. T. Hirsch;Z. J. Haskal;N. R. Hertzer;C. W. Bakal.
Journal of the American College of Cardiology (2006)
2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Thom W. Rooke;Alan T. Hirsch;Sanjay Misra;Anton N. Sidawy.
Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation.
Heribert Schunkert;Victor J. Dzau;Victor J. Dzau;Shiow Shin Tang;Alan T Hirsch.
Journal of Clinical Investigation (1990)
Critical issues in peripheral arterial disease detection and management: a call to action.
Jill J. F. Belch;Eric J. Topol;Giancarlo Agnelli;Michel Bertrand.
JAMA Internal Medicine (2003)
Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis
Deepak L. Bhatt;Kim A. Eagle;E. Magnus Ohman;Alan T. Hirsch.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: